The therapeutic potential of targeting the BRAF mutation in patients with colorectal cancer. [electronic resource]
Producer: 20171211Description: 2162-2169 p. digitalISSN:- 1097-4652
- Amino Acid Substitution -- genetics
- Antineoplastic Combined Chemotherapy Protocols -- therapeutic use
- Carbamates -- therapeutic use
- Cinnamates -- therapeutic use
- Colorectal Neoplasms -- drug therapy
- Drug Resistance, Neoplasm -- genetics
- ErbB Receptors -- antagonists & inhibitors
- Extracellular Signal-Regulated MAP Kinases -- metabolism
- Humans
- Imidazoles -- therapeutic use
- Indoles -- therapeutic use
- MAP Kinase Kinase Kinases -- antagonists & inhibitors
- Oximes -- therapeutic use
- Phosphoinositide-3 Kinase Inhibitors
- Piperazines -- therapeutic use
- Proto-Oncogene Proteins B-raf -- antagonists & inhibitors
- Sulfonamides -- therapeutic use
- Vemurafenib
No physical items for this record
Publication Type: Journal Article; Review
There are no comments on this title.
Log in to your account to post a comment.